Thursday, February 12, 2026
Home Business Space New ISS Research Project Aims ...
Space
Business Honor
20 August, 2024
NASA's most recent ISS project, which is funding creative solutions to improve treatment with $7 million, focuses on cancer research.
A new project under the Cancer Moonshot program calls for NASA's International Space Station (ISS) to play a key role in furthering cancer research. Five research teams have received money totaling over $7 million from the project, which was announced at the end of July. The Biological and Physical Sciences (BPS) branch of NASA and the ISS National Lab will manage these initiatives, which aim to investigate new cancer treatments by utilizing the ISS's unique microgravity environment.
Wake Forest Institute for Regenerative Medicine (WFIRM), University of Texas MD Anderson Cancer Center, University of California, San Diego, Eascra Biotech, and Cedars-Sinai Medical Center are among the sponsored teams. Each will make use of the ISS's microgravity to conduct cutting-edge research aimed at improving cancer therapies.
The CEO of the Center for the Advancement of Science in Space, Ray Lugo, highlighted the importance of this discovery and noted that it could have a significant impact on medical care on Earth. The initiatives will concentrate on different facets of cancer treatment, such as examining the behavior of T cells under microgravity.
Deep Space Biology, in partnership with the MD Anderson Cancer Center, Axiom Space, BioServe Space Technologies, and Mongoose Bio, is spearheading one noteworthy initiative. They are analyzing biological data with artificial intelligence, which should hasten the identification and approval of novel cancer treatments.
Co-founder of Deep Space Biology Montana Bilger highlighted how Yotta, their AI platform, could transform cancer research and treatment by offering new insights into T-cell dynamics in space.
This project shows a sustained dedication to utilizing space-based research for important medical discoveries, with the aim of advancing cancer therapy and improved patient outcomes all around the world.